Extrahepatic bile duct small cell adenocarcinoma
diseaseOn this page
Also known as extrahepatic bile duct small cell NECextrahepatic bile duct small cell neuroendocrine carcinomaOat cell carcinoma of extrahepatic bile ductOat cell carcinoma of the extrahepatic bile ductOat cell extrahepatic bile duct carcinomasmall cell adenocarcinoma of extrahepatic bile ductsmall cell adenocarcinoma of the extrahepatic bile ductsmall cell extrahepatic bile duct carcinomasmall cell extrahepatic bile duct neuroendocrine carcinoma
Summary
Extrahepatic bile duct small cell adenocarcinoma (MONDO:0003708) is a disease. A subtype of small cell carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | extrahepatic bile duct small cell adenocarcinoma |
| Mondo ID | MONDO:0003708 |
| DOID | DOID:5926 |
| NCIT | C5845 |
| UMLS | C1335979 |
| MedGen | 277648 |
| GARD | 0023628 |
| Is cancer (heuristic) | no |
Also known as: extrahepatic bile duct small cell NEC · extrahepatic bile duct small cell neuroendocrine carcinoma · Oat cell carcinoma of extrahepatic bile duct · Oat cell carcinoma of the extrahepatic bile duct · Oat cell extrahepatic bile duct carcinoma · small cell adenocarcinoma of extrahepatic bile duct · small cell adenocarcinoma of the extrahepatic bile duct · small cell extrahepatic bile duct carcinoma · small cell extrahepatic bile duct neuroendocrine carcinoma
Disease family
This is a subtype of small cell carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › neuroendocrine carcinoma › small cell carcinoma › extrahepatic bile duct small cell adenocarcinoma
Related subtypes (17): ovarian small cell carcinoma, colon small cell neuroendocrine carcinoma, urinary bladder small cell neuroendocrine carcinoma, esophageal small cell neuroendocrine carcinoma, ampulla of vater small cell neuroendocrine carcinoma, Bartholin gland small cell carcinoma, thymus small cell carcinoma, cervical small cell carcinoma, endometrial small cell carcinoma, gallbladder small cell neuroendocrine carcinoma, gastric small cell neuroendocrine carcinoma, laryngeal small cell carcinoma, pancreatic small cell neuroendocrine carcinoma, prostate small cell carcinoma, salivary gland small cell carcinoma, ureter small cell carcinoma, small cell lung carcinoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.